Contrast Enhanced Ultrasound in CT-undetermined Focal Liver Lesions

Abstract

Purpose: The purpose of this study was to examine the diagnostic accuracy of CEUS in the diagnosis of focal liver lesions, which were undetermined at CT scan.

Materials and Methods: From January 2010 to December 2010, patients with CT-undetermined focal liver lesions were included in this study. A total of 78 patients were evaluated: 41 men and 37 women, mean age 61.8 years; age range 30–91 years. All patients were examined with GE LOGIQ 9E ultrasound scanners with contrast-specific software, and SonoVue intravenous bolus. The standard of reference was composite consisting of: percutaneous biopsy, surgical resection, PET/CT and clinical follow-up.

Results: The 78 included patients had 163 undetermined focal liver lesions, mean size 1.1 cm, range 0.1–5.3 cm. There were 18 malignant and 145 benign liver lesions, as defined by the standard of reference. In differentiating between benign vs. malignant CEUS demonstrated sensitivity, specificity, PPV, NPV and accuracy of 94.4% (95% CI: 56.3–99.5%), 99.3% (95% CI: 94.9 –99.9%), 94.4% (95% CI: 56.3–99.5%), 99.3% (95% CI: 94.9–99.9%) and 98.7% (95% CI: 94.9–99.7%), respectively. If the CEUS-inconclusive results were assumed to indicate malignancy, then sensitivity, specificity, PPV, NPV and accuracy would be 95.8% (95% CI: 66.4–99.6%), 98.6% (95% CI: 94.4–99.7%), 92.0% (95CI: 65.1–98.6%), 99.3% (95% CI: 95.0–99.9%), 98.2% (95% CI: 94.4–99.5%).

Conclusion: The results of this study showed a high diagnostic accuracy for CEUS in undetermined focal liver lesions found by CT. Due to a high diagnostic accuracy of CEUS in this study, it was cautiously concluded that CEUS is useful in differentiating between malignant and benign focal liver lesions in clinical practice.

Key words

CEUS - CT - sensitivity - specificity - ultrasound

• References

• 1 Volk M, Strotzer M, Lenhart M, Techert J, Seitz J, Feuerbach S. Frequency of benign hepatic lesions incidentally detected with contrast-enhanced thin-section portal venous phase spiral CT. Acta Radiol 2001; 42: 172-175
• 2 Hohmann J, Skrok J, Basilico R, Jennett M, Müller A, Wolf KJ et al. Characterisation of focal liver lesions with unenhanced and contrast enhanced low MI real time ultrasound: on-site unblinded versus off-site blinded reading. Eur J Radiol 2012; 81: e317-e324
• 3 Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol 2011; 197: W256-W259
• 4 Albrecht T, Hohmann J, Oldenburg A, Skrok J, Wolf KJ. Detection and characterisation of liver metastases. Eur Radiol 2004; 14 (Suppl. 08) P25-P33
• 5 Bleuzen A, Tranquart F. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 2004; 14 (Suppl. 08) P53-P62
• 6 Westwood M, Joore M, Grutters J, Redekop K, Armstrong N, Lee K et al. Contrast-enhanced ultrasound using SonoVue(R) (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess 2013; 17: 1-243
• 7 Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004; 232: 420-430
• 8 Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012. Ultraschall Med 2013; 34: 11-29
• 9 Dai Y, Chen MH, Yin SS, Yan K, Fan ZH, Wu W et al. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?. Invest Radiol 2007; 42 (08) 596-603
• 10 von Herbay A, Westendorff J, Gregor M. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients. J Clin Ultrasound 2010; 38: 1-9
• 11 Ooi CC, Low SC, Schneider-Kolsky M, Lombardo P, Lim SY, Abu Bakar R et al. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study. J Med Imaging Radiat Oncol 2010; 54: 421-430
• 12 Laghi F, Catalano O, Maresca M, Sandomenico F, Siani A. Indeterminate, subcentimetric focal liver lesions in cancer patients: additional role of contrast-enhanced ultrasound. Ultraschall in Med 2010; 31: 283-288
• 13 Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Radiology 2003; 226: 24-28
• 14 Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M, Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001; 11: 1316-1328
• 15 Shinkins B, Thompson M, Mallett S, Perera R. Diagnostic accuracy studies: how to report and analyse inconclusive test results. Bmj 2013; 346: f2778
• 16 Quaia E. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound. Abdom Imaging 2012; 37: 580-590
• 17 Berry JD, Boxer ME, Rashid HI, Sidhu PS. Case report: microbubble contrast-enhanced ultrasound characteristics of multiple biliary hamartomas (von Meyenberg Complexes). Ultrasound 2004; 12: 95-97
• 18 Beaton C, Cochlin D, Kumar N. Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions. Eur J Surg Oncol 2010; 36: 43-46
• 19 Sporea I, Badea R, Popescu A, Sparchez Z, Sirli RL, Danila M et al. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions – a prospective multicenter study of its usefulness in clinical practice. Ultraschall in Med 2014; 35: 259-266
• 20 Quaia E, De Paoli L, Angileri R, Cabibbo B, Cova MA. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver. Eur J Radiol 2014; 83: 456-462
• 21 Tan CH, Bhosale PR, Das P, Crane CH, Viswanathan C, Raval B et al. Multidetector computed tomography follow-up of hypoattenuating small liver lesions in patients with rectal cancer. Am J Clin Oncol 2011; 34: 411-416
• 22 Lung PF, Jaffer OS, Akbar N, Sidhu PS, Ryan SM. Appearances of von meyenburg complex on cross sectional imaging. Journal of clinical imaging science 2013; 3: 22
• 23 Hohmann J, Loddenkemper C, Albrecht T. Assessment of a biliary hamartoma with contrast-enhanced sonography using two different contrast agents. Ultraschall in Med 2009; 30: 185-188